Perrigo | PRGO - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
AbbVie USD 5.57B 2.9B 2026-03
Abbott USD 2.39B 27M 2026-03
Bayer EUR -1.16B 735M 2025-09
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Dr.Reddys Laboratories INR 15.68B 2.38B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
J&J USD 7.82B 2.86B 2026-03
Merck USD 3.42B 3.32B 2025-12
Nestle CHF 7.24B 1.1B 2024-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 5.18B 6.82B 2026-03
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 61.81M 7.32M 2025-12
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zoetis USD 887M 15M 2025-09